• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.44% Nasdaq Down0.37%

    Codexis, Inc. (CDXS)

    3.82 0.00(0.00%) 4:00PM EST
    - Nasdaq Real Time Price
    ProfileGet Profile for:
    Codexis, Inc.
    200 Penobscot Drive
    Redwood City, CA 94063
    United States - Map
    Phone: 650-421-8100
    Website: http://www.codexis.com

    Index Membership:N/A
    Full Time Employees:91

    Business Summary 

    Codexis, Inc. develops biocatalysts for the pharmaceutical and fine chemicals markets in the United States and internationally. The company offers Codex biocatalyst panels and kits to pharmaceutical companies that are engaged in drug development and the marketing of approved drugs to allow them to screen and identify possible enzymatic manufacturing processes for their drug candidates and their marketed products. It also provides enzyme screening services and enzyme optimization services; and supplies enzymes, pharmaceutical intermediates, and active pharmaceutical ingredients. In addition, the company develops biocatalysts for use in the fine chemicals market, including food, animal feed, agricultural chemicals, and flavors and fragrances. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. Codexis, Inc. was founded in 2002 and is headquartered in Redwood City, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Codexis, Inc.

    Corporate Governance 
    Codexis, Inc.’s ISS Governance QuickScore as of Jul 1, 2013 is 10. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 10; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. John J. Nicols , 51
    Chief Exec. Officer, Pres and Director
    Mr. Gordon T. B. Sangster , 62
    Chief Financial Officer and Sr. VP
    Mr. Douglas T. Sheehy J.D., 48
    Chief Admin. Officer, Exec. VP, Gen. Counsel and Sec.
    Dr. James J. Lalonde Ph.D., 54
    Sr. VP of R&D
    Dr. John H. Grate Ph.D., 62
    Chief Science Officer and Sr. VP of Science & Innovation
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders